Initial US FDA approval year Generic name Brand name Target
2005 Sorafenib Nexavar Ttyrosine kinases
2012 Regorafenib Stivarga Ttyrosine kinases
2012 Cabozantinib Cabometys Ttyrosine kinases
2015 Lenvatinib Lenvima Ttyrosine kinases
FDA,US Food and Drug Administration; Hepatocellular cancer; TKIs, Ttyrosine kinases inhibitors. FDA,US Food and Drug Administration; Hepatocellular cancer; TKIs, Ttyrosine kinases inhibitors. FDA,US Food and Drug Administration; Hepatocellular cancer; TKIs, Ttyrosine kinases inhibitors. FDA,US Food and Drug Administration; Hepatocellular cancer; TKIs, Ttyrosine kinases inhibitors.